Cancer: latest news

Cancer resources

  • Non-HIV-related illnesses – cancers

    Kaposi’s sarcoma and non-Hodgkin’s lymphoma have become rarer since the introduction of effective HIV treatment, but still occasionally cause illness and death in people with HIV. Often, these people...

    From: Living with HIV

    Information level Level 2
  • Cervical and anal screening

    Infection with certain types of a common virus called human papillomavirus, or HPV, can cause cell changes in the cervix that can lead to cervical cancer. All HIV-positive...

    From: Booklets

    Information level Level 2
  • Non-Hodgkin’s lymphoma

    Non-Hodgkin’s lymphoma is an AIDS-defining cancer. A lymphoma is the name given to a tumour (or growth) of lymphocytes (white blood cells). Non-Hodgkin’s lymphoma (NHL)...

    From: Factsheets

    Information level Level 2
  • Kaposi's sarcoma

    Kaposi's sarcoma (KS) is an AIDS-defining cancer and was one of the first recognised HIV-related illnesses in the early 1980s. Unlike most cancers, which start...

    From: Factsheets

    Information level Level 2
  • Lung cancer

    Evidence from the UK and other countries shows that lung cancer is more common in HIV-positive people than the general HIV-negative population. Before effective HIV treatment...

    From: Factsheets

    Information level Level 2
  • Cervical cancer

    Human papillomavirus (HPV) is the underlying cause of cervical cancer. Infection with HPV is very common in the general population and is slightly more common...

    From: Factsheets

    Information level Level 2
  • Anal cancer

    Since potent and effective HIV treatment became available, the number of cases of the AIDS-defining cancers such as Kaposi’s sarcoma and non-Hodgkin’s lymphoma has fallen,...

    From: Factsheets

    Information level Level 2
  • Cancer

    Cancers are a range of diseases caused by uncontrolled cell division. A number of cancers occur more frequently among people with HIV than in the general...

    From: HIV treatments directory

    Information level Level 4
  • Hodgkin's disease

    Hodgkin's disease is a type of lymphoma - a tumour of lymph nodes - named after Thomas Hodgkin, a pathologist who first described it in...

    From: HIV treatments directory

    Information level Level 4
  • Kaposi's sarcoma

    Kaposi's sarcoma (KS) was first described in 1872 by the Hungarian dermatologist Moritz Kaposi. Before the AIDS epidemic it was a rare condition. There are four...

    From: HIV treatments directory

    Information level Level 4
  • Lung cancer

    Lung cancer is not an AIDS-defining illness. However, people with HIV have a greater chance of developing lung cancer than non-infected people, and as...

    From: HIV treatments directory

    Information level Level 4
  • Non-Hodgkin's lymphoma

    Non-Hodgkin's lymphoma (NHL) is a type of lymphoma - a tumour that involves the uncontrolled multiplication of a type of white blood cell called lymphocytes....

    From: HIV treatments directory

    Information level Level 4

Cancer features

Cancer in your own words

Cancer news from aidsmap

More news

Cancer news selected from other sources

  • How People With HIV Can Combat Their Raised Risk of Cancer

    HIV-positive people have a much higher risk of certain cancers than the general population. Here are some ways to help improve your chances of avoiding cancer.

    4 hours ago | Poz
  • The Link Between Protease Inhibitors and Cancer

    A large, multinational study published in JAIDS reports an increased risk of some cancers for people taking protease inhibitor-based combination antiretroviral therapy (PI-based cART) compared to non-nucleoside reverse transcriptase inhibitor-based cART (NNRTI-based cART). While any successful cART is known to decrease the risk of “AIDS-defining” cancers such as Kaposi sarcoma, the relationship between cART and other cancers has not been well understood.

    19 June 2015 | BETA blog
  • The Independent claims HPV vaccine unsafe. Science says The Independent is wrong.

    The Independent is the latest newspaper to do a hack job on the safety of the HPV vaccine and stoke false concerns about safety by publishing this poorly researched and alarmist piece on Sunday written by Paul Gallagher.

    02 June 2015 | Dr. Jen Gunter (blog)
  • Gender-neutral HPV vaccination

    Peter Baker is Campaign Director for HPV Action, a collaborative partnership of patient and professional organisations that are working together to achieve gender-neutral (both boys and girls) vaccination for the human papilloma virus (HPV). He presents a clear argument for introducing a gender-neutral vaccination programme in the UK, and highlights the potential public health benefits, long term savings in treatment and care and reduction in human suffering that would result.

    05 May 2015 | MEDFASH
  • Researchers develop new model to study why some HPV infections go away and others progress

    For people infected with the human papilloma virus (HPV), the likelihood of clearing the infection and avoiding HPV-related cancer may depend less on the body's disease-fighting arsenal than has been generally assumed. A new study finds that the body's ability to defeat the virus may be largely due to unpredictable division patterns in HPV-infected stem cells, rather than the strength of the person's immune response.

    01 April 2015 | EATG
  • HPV Vaccination Not Associated with Increase in Sexually Transmitted Infections

    A barrier to human papillomavirus (HPV) vaccination has been the concern that it may promote unsafe sexual activity, but a new study of adolescent girls finds that HPV vaccination was not associated with increases in sexually transmitted infections (STIs), according to an article published online by JAMA Internal Medicine.

    11 February 2015 | JAMA press release
  • Low CD4 count, suboptimal HIV treatment linked to higher anal cancer risk

    People with HIV who experienced extensive immune deficiency or who used early antiretroviral drugs before the advent of combination highly-active antiretroviral therapy (HAART) in the mid-90s may be at greater risk for developing anal cancer, according to a retrospective analysis published in the January 28 edition of AIDS.

    23 January 2015 | HIVandHepatitis.com
  • Anal Cancer and HPV: What do Gay Men Need to Know?

    A CDC recommendation report issued by the Advisory Committee on Immunization Practices released late this summer calls for a better understanding of anal cancer development and screening among a population at high risk—men who have sex with men (MSM). Although there’s still uncertainty about the best way to screen for and treat anal cancer, here’s what we know right now about who gets it, and what to look out for if you’re worried.

    14 January 2015 | BETA blog
  • Bone metastases in prostate cancer blocked by HIV drug

    Experiments in mice and in humans have indicated that the HIV drug maraviroc (Celsentri/Selzentry) could be used to prevent the spread of metastases (secondary caners) from prostate and other cancers. Experiments in mice showed a 60% reduction in metastases in animals treated with maraviroc.

    04 January 2015 | Medical news today
  • Heterosexual transmission of HPV to male oral tract via oral/genital route indicated by partner data

    A recent study claims to be the first to have established the association of oral infection in males with sexual behaviour, not just on the basis of their reported sexual behaviour, but through the collection of data from their partners.

    15 December 2014 | BMJ Blogs
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.